Prenatal NSAID Exposure and Birth Defects
Author Information
Author(s): Marleen M. H. J. van Gelder, Nel Roeleveld, Hedvig Nordeng
Primary Institution: Radboud University Nijmegen Medical Centre
Hypothesis
Does exposure to non-steroidal anti-inflammatory drugs (NSAIDs) during pregnancy increase the risk of birth defects?
Conclusion
Exposure to NSAIDs during the first 12 weeks of gestation does not seem to be associated with an increased risk of selected birth defects.
Supporting Evidence
- NSAID use during pregnancy is common, but the study found no significant increase in birth defects.
- Only a small percentage of women reported NSAID use during the first trimester.
- The study used a large cohort to assess the risks associated with NSAID exposure.
Takeaway
Taking certain pain medications during pregnancy doesn't seem to cause problems for babies, but we need to be careful because we didn't look at every possible issue.
Methodology
The study analyzed data from 69,929 women in the Norwegian Mother and Child Cohort Study, focusing on NSAID use and birth outcomes.
Potential Biases
Selection bias may have occurred due to the low participation rate in the cohort study.
Limitations
The small number of NSAID-exposed infants for individual birth defect categories limited the ability to detect specific associations.
Participant Demographics
The study included women enrolled in early pregnancy between 1999 and 2006, with a participation rate of 43.5%.
Statistical Information
Confidence Interval
0.4–1.1
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website